Menu Back toLS31: New System of Clinical Notification for Complexed Clinical Trials

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS31: New System of Clinical Notification for Complexed Clinical Trials

Session Chair(s)

Toshinori  Higashi, PhD

Toshinori Higashi, PhD

  • Regulatory Development Department
  • Janssen Pharmaceutical K.K., Japan

Speaker(s)

Daisuke  Sato

Daisuke Sato

  • Coordinator, Office of Review Management
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Noriko  Morikubo

Noriko Morikubo

  • Regulatory Strategy Group2, Japan Regulatory Portfolio Lead
  • Pfizer R&D Japan G.K., Japan
Hitomi  Okuma, MD, PhD

Hitomi Okuma, MD, PhD

  • Director, Research Planning Office
  • National Cancer Center Hospital, Japan

Contact us